This site is part of the Informa Connect Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 3099067.


Claes Gustafsson, Ph.D.
Chief Commercial Officer and Co-Founder at ATUM


ATUM’s Co-Founder and CCO Dr. Gustafsson pioneered and published on bioengineering driven by machine learning already back at Umeå University, Sweden 1993. After post-doc at UCSC and UCSF he was one of the first scientists at Kosan (acquired by Bristol-Myers Squibb), and then joined Maxygen to run the bioinformatics dept. In 2003 Claes and three colleagues from Maxygen founded DNA2.0, later renamed ATUM, to industrialize the implementation of machine learning and synthetic biology in biotechnology. The company today provides synthetic genes, protein production, protein engineering and transposon-mediated cell line development to customers ranging from protein pharma to food industry.

Claes Gustafsson, Ph.D.'s Network

Agenda Sessions

  • Building Better Antibodies from Genes to Cell Lines